NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

ATL, while I agree with you, I'll also remind you that during the trial GBM was redefined and some patients had what's no longer considered GBM. I believe that those cancers will certainly be covered by the label, but I believe it will go a big step further. Whether the label goes that far, or not, I believe Oncologists with brain cancer patients with operable tumors will go for DCVax-L in all brain cancers.

I certainly believe that when it comes to inoperable brain cancer, DCVax-Direct will be one way it will be treated in the future. While they may not be able to operate, a targeted injection of DCVax-Direct should be possible. Yesterday I believe there was substantial discussion of prostate cancer. I know they say most men who live long enough will get it, frequently it's only monitored if it's determined to be growing so slowly that seniors will likely die of other causes before it becomes a problem. With DCVax-Direct having virtually no negative side effects I believe it will be used in practically every prostate patient that objects to the side effects of nearly all the other treatments. Of course the key is DCVax-Direct proving it's effective in new trials, but based on what's previously been seen, it will happen.

Gary